|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs | |||||
| Amortization of deferred commissions costs | |||||
| Noncash stock-based compensation | |||||
| Noncash operating lease expense | |||||
| Noncash change in fair value of equity securities | |||||
| Noncash change in fair value of contingent consideration | |||||
| Noncash adjustment on headquarters sale leaseback | |||||
| Noncash impairment charges | |||||
| Noncash lease impairment | |||||
| Deferred income taxes | |||||
| Changes in operating assets and liabilities: | |||||
| Trade accounts receivable, net | |||||
| Operating lease assets and liabilities, net | |||||
| Operating lease liabilities | |||||
| Other current assets and Other assets | |||||
| Deferred commissions cost | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property and equipment | |||||
| Purchase of equity securities | |||||
| Proceeds from sale of headquarters, net | |||||
| Business combination, net of cash acquired | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Repurchase of common stock | |||||
| Proceeds from stock-based compensation plans | |||||
| Proceeds from issuance of convertible notes | |||||
| Purchase of capped calls | |||||
| Payment of contingent liability | |||||
| Payment of debt issuance costs | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Effects of exchange rate — changes in cash | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosures of cash flow information | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Noncash activities: | |||||
| Issuance of common stock for business combination | |||||
| Operating lease liabilities arising from obtaining right-of-use assets | |||||
Loading...